Name : IFITM1 Antibody
Supplier : BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price :263
SKU : GEN2897986104
| Long name | IFITM1 Primary Polyclonal Antibody |
| Also known as | IFITM1 PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | IFITM1 |
| Specificity | This is a highly specific antibody against IFITM1 |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Immunogen range | 108-125/125 |
| Subcellular location | Extracellular |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human IFITM1 |
| Gene ID number | 8519 |
| Swiss Prot | P13164 |
| Tested Applications | IF(IHC-P), IHC-P |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500) |
| Cross reactivity | Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | Active against multiple viruses, Acts as a positive regulator of osteoblast differentiation, Also implicated in cell adhesion and control of cell growth and migration, Can inhibit: influenza virus hemagglutinin protein-mediated viral entry, Dengue virus (DNV), Ebola virus (EBOV), MARV and EBOV GP1, Marburg virus (MARV), Plays a key role in the antiproliferative action of IFN-gamma either by inhibiting the ERK activation or by arresting cell growth in G1 phase in a p53-dependent manner, SARS coronavirus (SARS-CoV), West Nile virus (WNV), but preventing subsequent viral fusion and release of viral contents into the cytosol, human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV), including influenza A virus, permitting endocytosis, 2-mediated viral entry and SARS-CoV S protein-mediated viral entry, IFN-induced antiviral protein which inhibits the entry of viruses to the host cell cytoplasm |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | CD225, DSPA2a, Dispanin subfamily A member 2a, IFI17, IFITM1, Interferon-induced protein 17, Interferon-induced transmembrane protein 1, Interferon-inducible protein 9-27, LEU13, Leu-13 antigen, 9-27 |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | IFITM1 |
| Short name | IFITM1 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | interferon induced transmembrane protein 1 (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | 9-27 and CD225 and DSPA2a and IFI17 and LEU13, IFITM1 and IDBG-16232 and ENSG00000185885 and 8519, Plasma membranes, protein binding, this GO :0001503 and ossification and biological process this GO :0005057 and receptor signaling protein activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005886 and plasma membrane and cellular component this GO :0007166 and cell surface receptor signaling pathway and biological process this GO :0008285 and negative regulation of cell proliferation and biological process this GO :0009607 and response to biotic stimulus and biological process this GO :0009615 and response to virus and biological process this GO :0016020 and membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0019221 and cytokine-mediated signaling pathway and biological process this GO :0030336 and negative regulation of cell migration and biological process this GO :0034341 and response to interferon-gamma and biological process this GO :0035455 and response to interferon-alpha and biological process this GO :0035456 and response to interferon-beta and biological process this GO :0035556 and intracellular signal transduction and biological process this GO :0045071 and negative regulation of viral genome replication and biological process this GO :0045087 and innate immune response and biological process this GO :0045669 and positive regulation of osteoblast differentiation and biological process this GO :0046597 and negative regulation of viral entry into host cell and biological process this GO :0050776 and regulation of immune response and biological process this GO :0051607 and defense response to virus and biological process this GO :0060337 and type I interferon signaling pathway and biological process, this GO :0005057: receptor signaling protein activity, this GO :0005057: receptor signaling protein activity and also this GO :0005515: protein binding, this GO :0005515: protein binding, interferon induced transmembrane protein 1 |
| Identity | 5412 |
| Gene | IFITM1 |
| Long gene name | interferon induced transmembrane protein 1 |
| Synonyms gene | IFI17 |
| Synonyms gene name | interferon induced transmembrane protein 1 (9-27) |
| Synonyms | 9-27 CD225 |
| Synonyms name | interferon-induced transmembrane protein 1 |
| Locus | 11p15, 5 |
| Discovery year | 2000-02-11 |
| GenBank acession | J04164 |
| Entrez gene record | 8519 |
| Pubmed identfication | 7559564 |
| RefSeq identity | NM_003641 |
| Classification | CD molecules |
| Havana BLAST/BLAT | OTTHUMG00000165359 |